GOCO at a glance
GoHealth, Inc. (GOCO, SEC CIK 1808220) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on May 18, 2026, an 8-K current report on July 21, 2026 and Form 4 insider filings as recently as August 17, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), GoHealth, Inc. (GOCO) reported revenue of $361.8 million (down 54.7% from FY2024) and a net loss of $257.1 million. Diluted EPS was -$20.17.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $361.8M
- −54.7% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- Latest 8-K
- Jul 21, 2026
- Item 3.02 · Item 1.03 · Item 1.01 · Item 5.03 · Item 5.02 · Item 1.02 · Item 7.01 · Item 8.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Mar 31, 2026
Management Discussion & Analysis
- Revenue $11.914M, down 94.6% YoY from $220.972M
- Net loss margin (555.1)% vs (4.4)% YoY
- GoHealth Protect growth offset Medicare pullback; Sales per Submission $621 vs $724
- Adjusted EBITDA $(22.222)M, margin (186.5)% vs 19.0%
- Cash preservation, cost cuts, lender discussions, and potential restructuring amid uncertain liquidity and Medicare headwinds
Risk Factors
- New going-concern risk triggered by projected inability to maintain the liquidity covenant within 12 months
- Debt-default risk from potential acceleration if liquidity covenants or scheduled payments are missed
- Capital-structure risk from uncertain lender discussions involving possible change of control or restructuring
- Operational risk from cost-saving initiatives that may fail to restore covenant compliance
- Collateral enforcement risk because accelerated debt could exceed available liquidity for repayment
AI summary of the GOCO 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 3.02: Unregistered Sales of Equity Securities
- GoHealth converted into New GoHealth, LLC through its bankruptcy restructuring
- 100% of New Common Interests issued to Allowed First Lien Claim holders pro rata
Item 1.03: Bankruptcy or Receivership
- Existing GoHealth equity, including Class A and Class B shares, cancelled under the bankruptcy plan
- Restricted stock, RSUs, and other pre-effective-date equity rights also extinguished
Item 1.01: Entry into a Material Definitive Agreement
- $782.2M Takeback Credit Facility: $20.0M new money, $173.9M senior takeback, and $588.3M junior takeback loans
- Interest at Term SOFR plus 5.50%, subject to a 3.00% floor
Item 5.03: Amendments to Articles of Incorporation or Bylaws
- GoHealth converted from a corporation into New GoHealth, LLC under the restructuring plan
- New Limited Liability Company Agreement adopted effective immediately
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Existing GoHealth board dissolved upon the Plan’s Effective Date
- Reorganized GoHealth appointed Vijay Kotte, Scott Avila, Neal Goldman and Conor Colpoys as directors
Item 1.02: Termination of a Material Definitive Agreement
- Bankruptcy Plan effective date cancelled GoHealth’s superpriority senior secured credit agreement dated August 6, 2025
- Cancellation also covers the September 13, 2019 credit agreement and related debt obligations
Item 7.01: Regulation FD Disclosure
- GoHealth issued a press release on July 21, 2026 regarding the Plan’s effectiveness
- Exhibit 99.2 contains the substantive disclosure investors should review for Plan-related implications
Item 8.01: Other Events
- Planned Form 15 filing following bankruptcy emergence to deregister securities under Exchange Act Section 12(g)
- SEC reporting obligations, including Forms 10-K, 10-Q and 8-K, immediately suspended upon filing
Item EX-99.1: Item EX-99.1
- Bankruptcy Court confirmed GoHealth’s amended prepackaged Chapter 11 plan on July 20, 2026, moving the restructuring toward implementation
- Classes holding super-priority loans, first-lien claims, GoHealth Holdings interests, and Class A stock each accepted the Plan
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule
- Nasdaq delisting follows GoHealth’s June 7, 2026 Chapter 11 filing and concerns over existing shareholders’ residual recovery
- Trading suspension begins June 16, 2026; GoHealth will not appeal the delisting determination
Item 1.03: Bankruptcy or Receivership
- GoHealth and subsidiaries filed voluntary Chapter 11 bankruptcy on June 7, 2026, signaling severe balance-sheet distress
- Prepackaged restructuring plan supported by 100% of lenders and over 60% of Class A shareholders
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation
- Chapter 11 filing triggered defaults under GoHealth’s 2025 Superpriority Credit Agreement and 2019 Credit Agreement
- Outstanding principal and accrued interest became immediately due, including an invested-capital multiple under the Superpriority facility
Item 5.02: Departure/Appointment of Directors or Principal Officers
- CEO Vijay Kotte received approximately $2.87 million tied to Chapter 11 performance milestones
- Additional CEO cash awards depend on emergence and post-emergence performance through the ten-month performance period
Item 7.01: Regulation FD Disclosure
- Chapter 11 restructuring remains the central investor issue, with Bankruptcy Court approval and Plan confirmation still pending
- Existing Class A holders and GoHealth Holdings unit holders face limited recovery and potential cancellation of equity interests
AI summaries of GOCO 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for GOCO
Don't miss the next GOCO filing
- Alerts as it files. A push when GOCO files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut GOCO, by share count.
- Ask anything. An AI agent that reads every GOCO filing and answers with sources.
GOCO alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Burd Brad | D | Jul 21, 2026 | 157,070 | - |
| Burd Brad | D | Jul 21, 2026 | 940 | - |
| Burd Brad | D | Jul 21, 2026 | 48,726 | - |
| Shanahan Brendan Richard | D | Jul 21, 2026 | 237,275 | - |
| KOTTE VIJAY | D | Jul 21, 2026 | 1,347,396 | - |
| KOTTE VIJAY | D | Jul 21, 2026 | 188,888 | - |
| KOTTE VIJAY | D | Jul 21, 2026 | 83,333 | - |
| KOTTE VIJAY | D | Jul 21, 2026 | 83,333 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $734.7M | $798.9M | $361.8M |
| Operating Income | -$81.7M | -$7.0M | -$412.9M |
| Net Income | -$63.3M | -$2.9M | -$257.1M |
| Op. Margin | -11.1% | -0.9% | -114.1% |
| Net Margin | -8.6% | -0.4% | -71.1% |
| Balance Sheet | |||
| Total Assets | $1.5B | $1.5B | $987.4M |
| Equity | $231.0M | $241.8M | $37.9M |
| ROE | -27.4% | -1.2% | -678.9% |
| Per Share | |||
| EPS | - | $-0.66 | $-20.17 |
| Cash Flow | |||
| Operating CF | $109.1M | -$21.6M | -$121.9M |
Source: XBRL data in GoHealth, Inc. (GOCO)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
GOCO filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
8-K current reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Aug 17, 2026 | - | - | - |
| 4 | Aug 17, 2026 | - | - | - |
| 4 | Jul 23, 2026 | - | - | - |
| 4 | Jul 23, 2026 | - | - | - |
| 4 | Jul 23, 2026 | - | - | - |
| 8-K | Jul 21, 2026 | - | Analysis | - |
| 8-K | Jun 11, 2026 | - | Analysis | - |
| 8-K | Jun 8, 2026 | - | Analysis | |
| 10-Q | May 18, 2026 | Mar 31, 2026 | Analysis | |
| 10-K | Mar 31, 2026 | Dec 31, 2025 | - | |
| 8-K | Mar 31, 2026 | - | - | - |
| 8-K | Mar 20, 2026 | - | - | - |
| 10-Q | Nov 14, 2025 | Sep 30, 2025 | Analysis | |
| SC 13G | Aug 14, 2025 | - | - | |
| SC 13D | Aug 13, 2025 | - | - | |
| SC 13D | Aug 13, 2025 | - | - | |
| SC 13D | Aug 12, 2025 | - | - | |
| 10-Q | Aug 12, 2025 | Jun 30, 2025 | - | |
| 10-Q | May 16, 2025 | Mar 31, 2025 | - | |
| 10-K | Feb 27, 2025 | Dec 31, 2024 | - | |
| 10-Q | Nov 7, 2024 | Sep 30, 2024 | - | |
| 10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
| 10-Q | May 9, 2024 | Mar 31, 2024 | - | |
| 10-K | Mar 14, 2024 | Dec 31, 2023 | - | |
| 10-Q | Nov 9, 2023 | Sep 30, 2023 | - |
Related Financials companies
- AON · Aon plcInsurance Agents, Brokers & Service
- AJG · Arthur J. Gallagher & Co.Insurance Agents, Brokers & Service
- BWIN · Baldwin Insurance Group, Inc.Insurance Agents, Brokers & Service
- BRO · Brown & BrownInsurance Agents, Brokers & Service
- CRVL · CORVEL CORPInsurance Agents, Brokers & Service
- EHTH · eHealth, Inc.Insurance Agents, Brokers & Service
- ACT · Enact Holdings, Inc.Insurance Agents, Brokers & Service
- EQH · Equitable Holdings IncInsurance Agents, Brokers & Service
GOCO SEC filings: frequently asked questions
What was GOCO's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), GoHealth, Inc. (GOCO) reported revenue of $361.8 million (down 54.7% from FY2024) and a net loss of $257.1 million. Diluted EPS was -$20.17. The figures come from the XBRL data in the 10-K.
What did GOCO report in its latest 8-K?
GoHealth, Inc. (GOCO) filed an 8-K on July 21, 2026 reporting Item 3.02 (Unregistered Sales of Equity Securities), Item 1.03 (Bankruptcy or Receivership), Item 1.01 (Entry into a Material Definitive Agreement), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 5.02 (Departure/Appointment of Directors or Principal Officers), Item 1.02 (Termination of a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). GoHealth converted into New GoHealth, LLC through its bankruptcy restructuring.
What are the latest GOCO SEC filings?
GoHealth, Inc. (GOCO) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on May 18, 2026, an 8-K current report on July 21, 2026 and a Form 4 insider filing on August 17, 2026.
What is GOCO's SEC CIK number?
GoHealth, Inc. (GOCO)'s SEC Central Index Key (CIK) is 1808220. EDGAR lists every GOCO filing under that number.
Ask anything about GOCO
The research agent reads GOCO's filings, financials, insider trades and 13F holders, then answers with sources.